Citigroup’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5K | Sell |
19,296
-14
| -0.1% | -$15 | ﹤0.01% | 4337 |
|
|
2025
Q1 | $21K | Sell |
19,310
-495,601
| -96% | -$540K | ﹤0.01% | 4311 |
|
|
2024
Q4 | $778K | Sell |
514,911
-4
| -0% | -$6 | ﹤0.01% | 2754 |
|
|
2024
Q3 | $767K | Sell |
514,915
-714
| -0.1% | -$1.06K | ﹤0.01% | 2736 |
|
|
2024
Q2 | $835K | Sell |
515,629
-7,094
| -1% | -$11.5K | ﹤0.01% | 2372 |
|
|
2024
Q1 | $889K | Buy |
522,723
+2,116
| +0.4% | +$3.6K | ﹤0.01% | 2454 |
|
|
2023
Q4 | $1.61M | Buy |
520,607
+155,043
| +42% | +$481K | ﹤0.01% | 1806 |
|
|
2023
Q3 | $2.24M | Buy |
365,564
+301,244
| +468% | +$1.85M | ﹤0.01% | 1410 |
|
|
2023
Q2 | $403K | Buy |
64,320
+6,617
| +11% | +$41.4K | ﹤0.01% | 2878 |
|
|
2023
Q1 | $275K | Sell |
57,703
-58,343
| -50% | -$278K | ﹤0.01% | 2938 |
|
|
2022
Q4 | $1.01M | Sell |
116,046
-146,864
| -56% | -$1.28M | ﹤0.01% | 2004 |
|
|
2022
Q3 | $3.13M | Sell |
262,910
-258,145
| -50% | -$3.07M | ﹤0.01% | 1331 |
|
|
2022
Q2 | $7.43M | Buy |
521,055
+493,081
| +1,763% | +$7.03M | 0.01% | 936 |
|
|
2022
Q1 | $582K | Sell |
27,974
-70,764
| -72% | -$1.47M | ﹤0.01% | 2752 |
|
|
2021
Q4 | $2.28M | Buy |
98,738
+44,853
| +83% | +$1.04M | ﹤0.01% | 1875 |
|
|
2021
Q3 | $1.61M | Buy |
53,885
+406
| +0.8% | +$12.1K | ﹤0.01% | 2058 |
|
|
2021
Q2 | $1.83M | Buy |
53,479
+20,459
| +62% | +$699K | ﹤0.01% | 2155 |
|
|
2021
Q1 | $1.09M | Buy |
33,020
+30,445
| +1,182% | +$1M | ﹤0.01% | 2319 |
|
|
2020
Q4 | $158K | Buy |
+2,575
| New | +$158K | ﹤0.01% | 3378 |
|